Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67314-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- TRIM25 antibody
- Antibody type
- Monoclonal
- Description
- TRIM25 antibody (Cat. #67314-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1H6G1
- Vial size
- 20ul, 150ul
Submitted references Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis.
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.
TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB.
TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination.
Liu Z, Wang K, Jiang C, Chen Y, Liu F, Xie M, Yim WY, Yao D, Qian X, Chen S, Shi J, Xu K, Wang Y, Dong N
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 May;11(20):e2307319
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 May;11(20):e2307319
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.
Yan Y, Zhou S, Chen X, Yi Q, Feng S, Zhao Z, Liu Y, Liang Q, Xu Z, Li Z, Sun L
Signal transduction and targeted therapy 2024 Mar 4;9(1):58
Signal transduction and targeted therapy 2024 Mar 4;9(1):58
TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
Wei J, Wang L, Zhang Y, Sun T, Zhang C, Hu Z, Zhou L, Liu X, Wan J, Ma L
Oncogene 2023 Jun;42(26):2103-2112
Oncogene 2023 Jun;42(26):2103-2112
Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB.
Ge MX, Shi YK, Liu D
Experimental biology and medicine (Maywood, N.J.) 2022 Sep;247(17):1529-1541
Experimental biology and medicine (Maywood, N.J.) 2022 Sep;247(17):1529-1541
TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou S, Peng J, Xiao L, Zhou C, Fang Y, Ou Q, Qin J, Liu M, Pan Z, Hou Z
Cell death & disease 2021 May 8;12(5):463
Cell death & disease 2021 May 8;12(5):463
RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination.
Yang Z, Wang J, He B, Zhang X, Li X, Kuang E
eLife 2021 Jul 27;10
eLife 2021 Jul 27;10
No comments: Submit comment
No validations: Submit validation data